Cvijic Christine Mikail

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 92% 68% 82%
Transactions
6 17% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -5%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Cvijic Christine Mikail's trades of Neurogene Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
141.85
Quantity 4,042 +48.3%
Value US$1,028,425
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
486.23
Quantity 66,771 -20.1%
Value US$2,468,523
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
69.78
Quantity 82,678 -3.3%
Value US$4,469,267
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
34.58
Quantity 2,531 -2.7%
Value US$87,519
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
34.06
Quantity 739 -0.8%
Value US$25,170
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
32.44
Quantity 4,800 -4.9%
Value US$155,692
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
30.07
Quantity 4,800 -4.6%
Value US$144,351
US Neurogene Inc (NGNE)
Transaction date
Proposed sale
Price
28.94
Quantity 14,400
Value US$416,736
US Neurogene Inc (NGNE)
Transaction date
Sale
Price
21.62
Quantity 2,558 -2.4%
Value US$55,316
US Neurogene Inc (NGNE)
Transaction date
Sale
Price
22.02
Quantity 263 -0.2%
Value US$5,791
US Neurogene Inc (NGNE)
Transaction date
Sale
Price
21.25
Quantity 1,395 -1.3%
Value US$29,637
US Neurogene Inc (NGNE)
Transaction date
Sale
Price
20.42
Quantity 2,387 -2.2%
Value US$48,748
US Neurogene Inc (NGNE)
Transaction date
Planned sale
Price
25.11
Quantity 4,800 -4.2%
Value US$120,526
US Neurogene Inc (NGNE)
Transaction date
Proposed sale
Price
19.68
Quantity 9,600
Value US$188,928
US Neurogene Inc (NGNE)
Transaction date
Sale
Price
16.94
Quantity 4,501 -5.9%
Value US$76,247
US Neurogene Inc (NGNE)
Transaction date
Purchase
Price
20.48
Quantity 24,000 +45.4%
Value US$491,400
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-07
US Neurogene Inc (NGNE)
PlS Planned sale
4,042 +48.3%
141.85
US$1,028,425 		4,042 +48.3% 141.85 US$1,028,425
2026-07-07 2026-07-06
US Neurogene Inc (NGNE)
PlS Planned sale
66,771 -20.1%
486.23
US$2,468,523 		66,771 -20.1% 486.23 US$2,468,523
2026-07-02 2026-07-02
US Neurogene Inc (NGNE)
PlS Planned sale
82,678 -3.3%
69.78
US$4,469,267 		82,678 -3.3% 69.78 US$4,469,267
2026-07-02 2026-07-02
US Neurogene Inc (NGNE)
PlS Planned sale
2,531 -2.7%
34.58
US$87,519 		2,531 -2.7% 34.58 US$87,519
2026-07-02 2026-07-01
US Neurogene Inc (NGNE)
PlS Planned sale
739 -0.8%
34.06
US$25,170 		739 -0.8% 34.06 US$25,170
2026-05-08 2026-05-06
US Neurogene Inc (NGNE)
PlS Planned sale
4,800 -4.9%
32.44
US$155,692 		4,800 -4.9% 32.44 US$155,692
2026-05-08 2026-05-06
US Neurogene Inc (NGNE)
PlS Planned sale
4,800 -4.6%
30.07
US$144,351 		4,800 -4.6% 30.07 US$144,351
2026-05-06 2026-05-06
US Neurogene Inc (NGNE)
PrS Proposed sale
14,400
28.94
US$416,736 		14,400 28.94 US$416,736
2026-03-30 2026-03-26
US Neurogene Inc (NGNE)
S Sale
2,558 -2.4%
21.62
US$55,316 		2,558 -2.4% 21.62 US$55,316
2026-03-17 2026-03-13
US Neurogene Inc (NGNE)
S Sale
263 -0.2%
22.02
US$5,791 		263 -0.2% 22.02 US$5,791
2026-03-17 2026-03-13
US Neurogene Inc (NGNE)
S Sale
1,395 -1.3%
21.25
US$29,637 		1,395 -1.3% 21.25 US$29,637
2026-03-17 2026-03-13
US Neurogene Inc (NGNE)
S Sale
2,387 -2.2%
20.42
US$48,748 		2,387 -2.2% 20.42 US$48,748
2026-03-03 2026-02-27
US Neurogene Inc (NGNE)
PlS Planned sale
4,800 -4.2%
25.11
US$120,526 		4,800 -4.2% 25.11 US$120,526
2026-02-27 2026-02-27
US Neurogene Inc (NGNE)
PrS Proposed sale
9,600
19.68
US$188,928 		9,600 19.68 US$188,928
2025-03-17 2025-03-13
US Neurogene Inc (NGNE)
S Sale
4,501 -5.9%
16.94
US$76,247 		4,501 -5.9% 16.94 US$76,247
2024-11-25 2024-11-22
US Neurogene Inc (NGNE)
B Purchase
24,000 +45.4%
20.48
US$491,400 		24,000 +45.4% 20.48 US$491,400